These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8228348)

  • 21. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells.
    Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
    Kageyama S; Mimoto T; Murakawa Y; Nomizu M; Ford H; Shirasaka T; Gulnik S; Erickson J; Takada K; Hayashi H
    Antimicrob Agents Chemother; 1993 Apr; 37(4):810-7. PubMed ID: 8494379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 protease inhibitors containing statine: inhibitory potency and antiviral activity.
    Fehrentz JA; Chomier B; Bignon E; Venaud S; Chermann JC; Nisato D
    Biochem Biophys Res Commun; 1992 Oct; 188(2):865-72. PubMed ID: 1445327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibition of alfa interferon and ampligen of human immunodeficiency virus (HIV) replication in monocyte-macrophage subpopulations].
    Bergamini A; Ercoli L; Perno CF
    Medicina (Firenze); 1990; 10(1):34-6. PubMed ID: 2381279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.
    Kinchington D; Galpin S; Jaroszewski JW; Ghosh K; Subasinghe C; Cohen JS
    Antiviral Res; 1992 Jan; 17(1):53-62. PubMed ID: 1736810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus.
    Aquaro S; Guenci T; Di Santo F; Francesconi M; Caliò R; Perno CF
    Antiviral Res; 2004 Feb; 61(2):133-7. PubMed ID: 14670588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes.
    Bergamini A; Perno CF; Balzarini J; Capozzi M; Marinelli L; Milanese G; Pesce CD; Calió R; Rocchi G
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1239-47. PubMed ID: 1381599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative modifications of kynostatin-272, a potent human immunodeficiency virus type 1 protease inhibitor: potential mechanism for altered activity in monocytes/macrophages.
    Davis DA; Read-Connole E; Pearson K; Fales HM; Newcomb FM; Moskovitz J; Yarchoan R
    Antimicrob Agents Chemother; 2002 Feb; 46(2):402-8. PubMed ID: 11796349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified oligopeptides designed to interact with the HIV-1 proteinase inhibit viral replication.
    Grinde B; Hungnes O; Tjøtta E
    Arch Virol; 1990; 114(3-4):167-73. PubMed ID: 2241573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.
    Kim SG; Hatta T; Tsukahara S; Nakashima H; Yamamoto N; Shoji Y; Takai K; Takaku H
    Bioorg Med Chem; 1995 Jan; 3(1):49-54. PubMed ID: 8612046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a human immunodeficiency virus protease inhibitor on human monocyte function.
    Bugelski PJ; Kaplan JM; Hart TK; Miller J; Laydon JT; Lee JC; Dreyer GB; Kirsh R
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1951-8. PubMed ID: 1493045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.
    Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L
    Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes.
    Aquaro S; Perno CF; Balestra E; Balzarini J; Cenci A; Francesconi M; Panti S; Serra F; Villani N; Caliò R
    J Leukoc Biol; 1997 Jul; 62(1):138-43. PubMed ID: 9226005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 proteinase is required for synthesis of pro-viral DNA.
    Baboonian C; Dalgleish A; Bountiff L; Gross J; Oroszlan S; Rickett G; Smith-Burchnell C; Troke P; Merson J
    Biochem Biophys Res Commun; 1991 Aug; 179(1):17-24. PubMed ID: 1652947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
    Davis DA; Brown CA; Singer KE; Wang V; Kaufman J; Stahl SJ; Wingfield P; Maeda K; Harada S; Yoshimura K; Kosalaraksa P; Mitsuya H; Yarchoan R
    Antiviral Res; 2006 Nov; 72(2):89-99. PubMed ID: 16687179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell specific uptake of antiretroviral drugs: AZT coupled to LDL inhibits HIV replication in human macrophages.
    Mankertz J; von Baeyer H; Rokos K; Nündel M; Pauli G; Riedel E
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):85-8. PubMed ID: 7757316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of HIV-1 protease.
    Meek TD
    J Enzyme Inhib; 1992; 6(1):65-98. PubMed ID: 1285304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro.
    Johnson VA; Merrill DP; Chou TC; Hirsch MS
    J Infect Dis; 1992 Nov; 166(5):1143-6. PubMed ID: 1328402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-human immunodeficiency virus type 1 activities of U-90152 and U-75875 in human brain cell cultures.
    Peterson PK; Gekker G; Hu S; Chao CC
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2465-8. PubMed ID: 7530933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddI.
    Chokekijchai S; Shirasaka T; Weinstein JN; Mitsuya H
    Antiviral Res; 1995 Sep; 28(1):25-38. PubMed ID: 8585758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.